ANDA Submissions Drop To Start FY 2021, Perhaps Forced Down By COVID-19

 
• By Derrick Gingery
Bottle of generic drugs
FDA ANDA approvals were ahead of their FY 2020 pace in the first quarter of FY 2021. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics